Brian C Stephenson, Chief Financial Officer at Faeth Therapeutics, bought SNSE on Jun 22, 2026
Prices as of Jun 11 · price update delayed · Every feed →
▲ BUY$36.4K1,797 shares at $20.23Brian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
SNSE since disclosure
SNSE has not closed a trading day since the disclosure yet
Similar stocks (XLV) since disclosure
SNSE has not closed a trading day since the disclosure yet
XLV — its sector index fund
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$48.9Kdisclosed Jun 24 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$11Kdisclosed Jun 24 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$165Kdisclosed Jun 24 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$8.5Kdisclosed Jun 24 · filed 2 days after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$77.5Kdisclosed Jun 24 · filed 2 days after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$35.5Kdisclosed Jun 24 · filed 2 days after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$23.3Kdisclosed Jun 24 · filed 2 days after the trade